Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans

Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Timely administration of antibiotics approved for the treatment of anthrax disease may prevent associated morbidity and mortality. However, any delay in initiating antimicrobial therapy may result in inc...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Malkevich, Nina V., Hopkins, Robert J., Bernton, Edward, Meister, Gabriel T., Vela, Eric M., Atiee, George, Johnson, Virginia, Nabors, Gary S., Aimes, Ronald T., Ionin, Boris, Skiadopoulos, Mario H.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2014
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068543/
https://ncbi.nlm.nih.gov/pubmed/24733473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02295-13
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы